References
- Barton JR, Sibai BM. Gastrointestinal complications of pre-eclampsia. Semin Perinatol 2009;33:179–188.
- Fonseca JE, Méndez F, Cataño C, Arias F. Dexamethasone treatment does not improve the outcome of women with HELLP syndrome: a double-blind, placebo-controlled, randomized clinical trial. Am J Obstet Gynecol 2005;193:1591–1598.
- Woudstra DM, Chandra S, Hofmeyr GJ, Dowswell T. Corticosteroids for HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome in pregnancy. Cochrane Database Syst Rev 2010;CD008148.
- Isler CM, Barrilleaux PS, Magann EF, Bass JD, Martin JN Jr. A prospective, randomized trial comparing the efficacy of dexamethasone and betamethasone for the treatment of antepartum HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol 2001;184:1332–7; discussion 1337.
- Isler CM, Magann EF, Rinehart BK, Terrone DA, Bass JD, Martin JN Jr. Dexamethasone compared with betamethasone for glucocorticoid treatment of postpartum HELLP syndrome. Int J Gynaecol Obstet 2003;80:291–297.
- Hintze J. NCSS 2007. Kaysville, Utah, USA; 2007.
- (RevMan) RM. Version 5.1 ed. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration; 2011.
- (Electronic Version): StatSoft Inc. Electronic Statistics Textbook. Tulsa, OK: StatSoft; 2011.
- Singh G. Conventional approach of combining p-values using chi-square test: an essence of meta analysis. Internet J Med Inform 2007;3.
- Buttgereit F, Brand MD, Burmester GR. Equivalent doses and relative drug potencies for non-genomic glucocorticoid effects: a novel glucocorticoid hierarchy. Biochem Pharmacol 1999;58:363–368.
- Vidaeff AC, Blackwell SC. Potential risks and benefits of antenatal corticosteroid therapy prior to preterm birth in pregnancies complicated by severe fetal growth restriction. Obstet Gynecol Clin North Am 2011;38:205–14, ix.
- Sziller I, Babula O, Hupuczi P, Nagy B, Rigó B, Szabó G, Papp Z, et al. Mannose-binding lectin (MBL) codon 54 gene polymorphism protects against development of pre-eclampsia, HELLP syndrome and pre-eclampsia-associated intrauterine growth restriction. Mol Hum Reprod 2007;13:281–285.
- Miller SL, Chai M, Loose J, Castillo-Meléndez M, Walker DW, Jenkin G, Wallace EM. The effects of maternal betamethasone administration on the intrauterine growth-restricted fetus. Endocrinology 2007;148:1288–1295.
- Miller SL, Supramaniam VG, Jenkin G, Walker DW, Wallace EM. Cardiovascular responses to maternal betamethasone administration in the intrauterine growth-restricted ovine fetus. Am J Obstet Gynecol 2009;201:613.e1–613.e8.
- Edwards A, Baker LS, Wallace EM. Changes in umbilical artery flow velocity waveforms following maternal administration of betamethasone. Placenta 2003;24:12–16.
- Robertson MC, Murila F, Tong S, Baker LS, Yu VY, Wallace EM. Predicting perinatal outcome through changes in umbilical artery Doppler studies after antenatal corticosteroids in the growth-restricted fetus. Obstet Gynecol 2009;113:636–640.